期刊文献+

高同型半胱氨酸血症与冠心病心力衰竭关联分析 被引量:1

Association Between High Homocysteine and Coronary Heart Disease With Heart Failure
下载PDF
导出
摘要 目的:观察高同型半胱氨酸血症(HHCY)与冠心病心力衰竭的相关性。方法选择我院2013年2月~2015年2月收治的53例冠心病心力衰竭患者作为观察组,选择冠心病但无心力衰竭作为对照组1;选择无冠心病及慢性心衰患者作为对照组2。对比观察三组患者HCY水平及不同心功能分级下患者的HCY水平情况。结果观察组、对照组1患者发生HHCY比例高于对照组2患者(P<0.05)。观察组与对照组1患者HCY浓度与对照组2比较,差异具有统计学意义(P<0.05)。NYHAIII患者与NYHAIV患者HCY浓度高于NYHAII患者(P<0.05)。结论 HHCY与冠心病心力衰竭呈正相关关系,是心衰及冠心病的危险因素。 Objective Observation of hyperhomocysteinemia (HHCY) and coronary heart relevance. Methods 53 cases of patients with coronary heart disease were chosen as the observation group in our hospital from February 2013 to February 2015, select coronary heart disease but without heart failure as the control group 1, choose without coronary heart disease and chronic heart failure patients as a control group 2. Comparative study of three groups of patients HCY levels and cardiac function under different circumstances HCY levels in patients. Results Observation group and control group 1 was significantly higher in patients HHCY 2 patients (P〈0.05). Observation group and control group 1 patients HCY concentration and control group 2 compared the results with a signiifcant difference (P〈0.05). NYHAIII patients with HCY concentrations were significantly higher than NYHAII and NYHAIV patients (P〈0.05). Conclusion HHCY and positively correlated with coronary heart disease, heart failure and is a risk factor for coronary heart disease.
作者 李莉 肖童
出处 《中国继续医学教育》 2015年第24期101-102,共2页 China Continuing Medical Education
关键词 高同型半胱氨酸血症 冠心病心力衰竭 同型半胱氨 Hyperhomocysteinemia Coronary heart with heart failure Homocysteic ammonia
  • 相关文献

参考文献4

二级参考文献40

  • 1陆再英,钟南山.内科学.7版,北京:人民卫生出版社.2010:112-113.
  • 2Wilcken DE, Wilcken B. The pathogenesis of coronary artery dis-ease. A possible role for methionine metabolism. J Clin Invest,1976, 57(4) :1079-1082.
  • 3Steed MM, Tyagi SC. Mechanisms of cardiovascular remodeling inhyperhomocysteinemia. Antioxid Redox Signal, 2011, 15 (7):1927-1943.
  • 4Bhargava S,Ali A,Manocha A,et al. Homocysteine in occlusivevascular disease : a risk marker or risk factor. Indian J BiochemBiophys, 2012,49(6) :414420.
  • 5McCully KS. Vascular pathology of homocysteinemia: implicationsfor the pathogenesis of arteriosclerosis. Am J Pathol,1969,56(1):111-128.
  • 6Colon Lopez V, Haan MN, Aiello AE, et al. Fasting total homo-cysteine (tHcy) concentration and mortality in older Mexican A-mericans. J Nutr Health Aging, 2008,12( 10) :685-689.
  • 7Homocysteine Studies Collaboration. Homocysteine and risk of is-chemic heart disease and stroke : a meta-analysis. JAMA,2002,288(16) :2015-2022.
  • 8Al^ssio AC, Santos CX, Debbas V,et al. Evaluation of mild hy-perhomocysteinemia during the development of atherosclerosis inapolipoprotein E-deficient and normal mice. Exp Mol Pathol,2011,90(1) :45-50.
  • 9Zhang D, Chen Y, Xie X, et al. Homocysteine activates vascularsmooth muscle cells by DNA demethylation of platelet-derivedgrowth factor in endothelial cells. J Mol Cell Cardiol, 2012, 53(4):487-496.
  • 10Galan P, Kesse-Guyot E, Czemichow S, et al. Effects of B vita-mins and omega 3 fatty acids on cardiovascular diseases : a random-ised placebo controlled trial. BMJ, 2010,341 :c6273.

共引文献65

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部